Effects of fasudil in patients with high-altitude pulmonary hypertension

Eur Respir J. 2012 Feb;39(2):496-8. doi: 10.1183/09031936.00095211.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives*
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / therapeutic use
  • Acclimatization
  • Altitude Sickness / complications
  • Altitude Sickness / drug therapy*
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Treatment Outcome
  • Vasodilator Agents / therapeutic use*

Substances

  • Vasodilator Agents
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • fasudil